Negligible-Cost and Weekend-Free Chemically Defined Human iPSC Culture
Summary: Human induced pluripotent stem cell (hiPSC) culture has become routine, yet the cost of pluripotent cell media, frequent medium changes, and the reproducibility of differentiation have remained restrictive. Here, we describe the formulation of a hiPSC culture medium (B8) as a result of the...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-02-01
|
Series: | Stem Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213671119304461 |
id |
doaj-02ff6b71bbf049cbb92ceee86f3339ee |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hui-Hsuan Kuo Xiaozhi Gao Jean-Marc DeKeyser K. Ashley Fetterman Emily A. Pinheiro Carly J. Weddle Hananeh Fonoudi Michael V. Orman Marisol Romero-Tejeda Mariam Jouni Malorie Blancard Tarek Magdy Conrad L. Epting Alfred L. George, Jr. Paul W. Burridge |
spellingShingle |
Hui-Hsuan Kuo Xiaozhi Gao Jean-Marc DeKeyser K. Ashley Fetterman Emily A. Pinheiro Carly J. Weddle Hananeh Fonoudi Michael V. Orman Marisol Romero-Tejeda Mariam Jouni Malorie Blancard Tarek Magdy Conrad L. Epting Alfred L. George, Jr. Paul W. Burridge Negligible-Cost and Weekend-Free Chemically Defined Human iPSC Culture Stem Cell Reports |
author_facet |
Hui-Hsuan Kuo Xiaozhi Gao Jean-Marc DeKeyser K. Ashley Fetterman Emily A. Pinheiro Carly J. Weddle Hananeh Fonoudi Michael V. Orman Marisol Romero-Tejeda Mariam Jouni Malorie Blancard Tarek Magdy Conrad L. Epting Alfred L. George, Jr. Paul W. Burridge |
author_sort |
Hui-Hsuan Kuo |
title |
Negligible-Cost and Weekend-Free Chemically Defined Human iPSC Culture |
title_short |
Negligible-Cost and Weekend-Free Chemically Defined Human iPSC Culture |
title_full |
Negligible-Cost and Weekend-Free Chemically Defined Human iPSC Culture |
title_fullStr |
Negligible-Cost and Weekend-Free Chemically Defined Human iPSC Culture |
title_full_unstemmed |
Negligible-Cost and Weekend-Free Chemically Defined Human iPSC Culture |
title_sort |
negligible-cost and weekend-free chemically defined human ipsc culture |
publisher |
Elsevier |
series |
Stem Cell Reports |
issn |
2213-6711 |
publishDate |
2020-02-01 |
description |
Summary: Human induced pluripotent stem cell (hiPSC) culture has become routine, yet the cost of pluripotent cell media, frequent medium changes, and the reproducibility of differentiation have remained restrictive. Here, we describe the formulation of a hiPSC culture medium (B8) as a result of the exhaustive optimization of medium constituents and concentrations, establishing the necessity and relative contributions of each component to the pluripotent state and cell proliferation. The reagents in B8 represent only 3% of the costs of commercial media, made possible primarily by the in-lab generation of three E. coli-expressed, codon-optimized recombinant proteins: fibroblast growth factor 2, transforming growth factor β3, and neuregulin 1. We demonstrate the derivation and culture of 34 hiPSC lines in B8 as well as the maintenance of pluripotency long term (over 100 passages). This formula also allows a weekend-free feeding schedule without sacrificing capacity for differentiation. : In this article, Burridge and colleagues describe the formulation of a hiPSC culture medium called B8 as a result of exhaustive optimization. The reagents in B8 represent only 3% of the costs of commercial media. B8 is suitable for both derivation and long-term culture of hiPSCs and allows a weekend-free feeding schedule without sacrificing capacity for differentiation. Keywords: human induced pluripotent stem cell, pluripotent state, culture media, weekend-free, differentiation, chemically defined, FGF2 |
url |
http://www.sciencedirect.com/science/article/pii/S2213671119304461 |
work_keys_str_mv |
AT huihsuankuo negligiblecostandweekendfreechemicallydefinedhumanipscculture AT xiaozhigao negligiblecostandweekendfreechemicallydefinedhumanipscculture AT jeanmarcdekeyser negligiblecostandweekendfreechemicallydefinedhumanipscculture AT kashleyfetterman negligiblecostandweekendfreechemicallydefinedhumanipscculture AT emilyapinheiro negligiblecostandweekendfreechemicallydefinedhumanipscculture AT carlyjweddle negligiblecostandweekendfreechemicallydefinedhumanipscculture AT hananehfonoudi negligiblecostandweekendfreechemicallydefinedhumanipscculture AT michaelvorman negligiblecostandweekendfreechemicallydefinedhumanipscculture AT marisolromerotejeda negligiblecostandweekendfreechemicallydefinedhumanipscculture AT mariamjouni negligiblecostandweekendfreechemicallydefinedhumanipscculture AT malorieblancard negligiblecostandweekendfreechemicallydefinedhumanipscculture AT tarekmagdy negligiblecostandweekendfreechemicallydefinedhumanipscculture AT conradlepting negligiblecostandweekendfreechemicallydefinedhumanipscculture AT alfredlgeorgejr negligiblecostandweekendfreechemicallydefinedhumanipscculture AT paulwburridge negligiblecostandweekendfreechemicallydefinedhumanipscculture |
_version_ |
1724798366182801408 |
spelling |
doaj-02ff6b71bbf049cbb92ceee86f3339ee2020-11-25T02:36:51ZengElsevierStem Cell Reports2213-67112020-02-01142256270Negligible-Cost and Weekend-Free Chemically Defined Human iPSC CultureHui-Hsuan Kuo0Xiaozhi Gao1Jean-Marc DeKeyser2K. Ashley Fetterman3Emily A. Pinheiro4Carly J. Weddle5Hananeh Fonoudi6Michael V. Orman7Marisol Romero-Tejeda8Mariam Jouni9Malorie Blancard10Tarek Magdy11Conrad L. Epting12Alfred L. George, Jr.13Paul W. Burridge14Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USADepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USADepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USADepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USADepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USADepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USADepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USADepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USADepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USADepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USADepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USADepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USADepartments of Pediatrics and Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USADepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USADepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Corresponding authorSummary: Human induced pluripotent stem cell (hiPSC) culture has become routine, yet the cost of pluripotent cell media, frequent medium changes, and the reproducibility of differentiation have remained restrictive. Here, we describe the formulation of a hiPSC culture medium (B8) as a result of the exhaustive optimization of medium constituents and concentrations, establishing the necessity and relative contributions of each component to the pluripotent state and cell proliferation. The reagents in B8 represent only 3% of the costs of commercial media, made possible primarily by the in-lab generation of three E. coli-expressed, codon-optimized recombinant proteins: fibroblast growth factor 2, transforming growth factor β3, and neuregulin 1. We demonstrate the derivation and culture of 34 hiPSC lines in B8 as well as the maintenance of pluripotency long term (over 100 passages). This formula also allows a weekend-free feeding schedule without sacrificing capacity for differentiation. : In this article, Burridge and colleagues describe the formulation of a hiPSC culture medium called B8 as a result of exhaustive optimization. The reagents in B8 represent only 3% of the costs of commercial media. B8 is suitable for both derivation and long-term culture of hiPSCs and allows a weekend-free feeding schedule without sacrificing capacity for differentiation. Keywords: human induced pluripotent stem cell, pluripotent state, culture media, weekend-free, differentiation, chemically defined, FGF2http://www.sciencedirect.com/science/article/pii/S2213671119304461 |